Detalhe da pesquisa
1.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901076
2.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603996
3.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227025
4.
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Integr Cancer Ther
; 16(2): 165-175, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27627986
5.
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Breast Care (Basel)
; 11(5): 315-322, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27920623